International Journal of Medical and Dental Sciences

Open Access Open Access  Restricted Access Subscription Access

Association of Micro and Macrovascular Complications with Fatty Liver in Patients with Type 2 Diabetes Mellitus


Affiliations
1 Medicine, GSL General Hospital, Rajahmundry, India
2 Pathology, GSL General Hospital, Rajahmundry, India
 

Background:Fatty liver is a fairly common entity seen in the diabetic population. Studies showed that liver adiposity is independently associated with Insulin Resistance and can substantially increase the risk of various micro and macrovascular complications of diabetes mellitus.

Aims: Identifying various micro and macrovascular complications and finding their association with fatty liver disease in type 2 diabetes patients.

Material and methods: 141 diabetic patients admitted in a tertiary care center over a two year period were screened for fatty liver by ultrasonography of the abdomen and were classified into FL (fatty Liver) group and NFL (non fatty liver) group. All patients were investigated for complications like nephropathy, neuropathy, retinopathy, cardiac and peripheral vascular disease. Statistical analysis was done to find the association of complications with fatty liver.

Results: out of 141 patients, 49 (35%) had fatty liver. Leading complication was neuropathy (31.2%), followed by nephropathy (11.3%), retinopathy (10.6%), cardiac disease (9.2%) and peripheral vascular disease (3.55). Between FL and NFL groups, Diabetic neuropathy (40.8% vs 23.9%) and cardiac disease (16.3% vs 5.4%) showed statical significance (p<0.05), while other complications were more or less equally prevalent in the two groups.

Conclusions: Fatty liver is seen in one third of diabetic patients. vascular complications like neuropathy and cardiac disease are more commonly seen in diabetic patients with fatty liver than those without fatty liver.


Keywords

Fatty Liver, Diabetes, Vascular Complications.
User
Notifications
Font Size


  • Chitturi S, Farrell G C, Hashimoto E, Saibara T, Lau G K, Sollano J D. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007;22:778.

  • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124.

  • Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434.

  • Wen-Shan Lv, Rui-Xia Sun, Yan-Yan Gao, JunPing Wen, Rong-Fang Pan, Li Li, et al. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes, World J Gastroenterol 2013 May 28;19(20):3134–42.

  • Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;12:666-673.

  • Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008;19:15641570.

  • Lee YI, Lim Y-S, Park HS. Colorectal neoplasms in relation to nonalcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol 2012;27:91-95.

  • Musso G, Cassader M, Olivetti C. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and metaanalysis. Obes Rev 2013;14:417-431.

  • Moon S-S, Lee Y-S, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 2012;42:423-429.

  • Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R, McCullough AJ.Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2012;57:528-534.

  • Zueff LFN, Martins WP, Vieira CS, Ferriani RA. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 2012;39:341-347.

  • Armstrong MJ, Adams LA, Canbay A, Syn WK. Hepatology 2013; Retrieved from http://http://onlinelibrary.wiley.com /doi/ 10.1002/hep.26717/citedby.

  • Krishnan A, J Venkatraman. 52 Association of non-alcoholic fatty liver with type 2 diabetes mellitus and its biochemical predictors. Journal of Clinical and Experimental Hepatology 2012;2(1):S29.

  • Viswanathan, Vijay, Mahesh Kadiri, Srikanth Medimpudi, and Satyavani Kumpatla. "Association of non-alcoholic fatty liver disease with diabetic microvascular and macrovascular complications in South Indian diabetic subjects. International Journal of Diabetes in Developing Countries 2010;30(4): 208.

  • Obrosova IG,MJ Stevens. Effect of dietary taurine supplementation on GSH and NAD(P)redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.Invest Ophthalmol Vis Sci 1999; 40(3):680-8.

  • Van den Enden MK, JR Nyengaard, E Ostrow, Burgan JH, Williamson JR. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 1995; 36(8):1675-85.

  • Langner CA, EH Birkenmeier, KA Roth, Bronson RT, Gordon JL. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J Biol Chem 1991; 266(18):11955-64.

  • Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008;47:51-8.

  • Fallo F, Dalla Pozza A, Sonino N, Lupia M, Tona F, Federspil G et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009;19:646-53.

  • Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006;40:949-55.

  • Huang Y, Bi Y, Xu M, Ma Z, Xu Y, Wang T et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 2012 Sep;32(9):2321-6. Epub 2012 Jul 19.

  • Yu-Tao Zhan, Chuan Zhang. Non-Alcoholic Fatty Liver Disease Is not Related to the Incidence of Diabetic Nephropathy in Type 2 Diabetes. Int J Mol Sci 2012;13(11):1469814706.

  • Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-133.

  • Lee DH, Jacobs DR, Gross M, Steffes M. Serum gammaglutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2005;51:1185-1191.

  • Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007;53:71-77.

  • Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metab Clin Exp 2008;57:569-576.

  • Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008;19:15641570.

  • Yeon Kim B, Chan Hee J, Mok JO, Sung KK, Chul Hee K. Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non‐alcoholic fatty liver disease. Journal of Diabetes Investigation 2013; Retrieved from http://onlinelibrary .wiley.com /doi/10.1111/jdi.12139/citedby.

  • Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I et al. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association with Cardiovascular Disease among Type 2 Diabetic Patients. Diabetes Care 2007;30:1212–18.

  • Targher G, Bertolini L, Zoppini G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 2005;22:999– 1004.

  • Chandran M, Phillips S A, Ciaraldi T, Henry R R. Adiponectin: More Than Just Another Fat Cell Hormone? Diabetes Care 2003;26:2442–2450.


Abstract Views: 280

PDF Views: 132




  • Association of Micro and Macrovascular Complications with Fatty Liver in Patients with Type 2 Diabetes Mellitus

Abstract Views: 280  |  PDF Views: 132

Authors

Vaddadi Suresh
Medicine, GSL General Hospital, Rajahmundry, India
N. S. R. C. Guptha
Medicine, GSL General Hospital, Rajahmundry, India
E. Usha Bhargavi
Pathology, GSL General Hospital, Rajahmundry, India

Abstract


Background:Fatty liver is a fairly common entity seen in the diabetic population. Studies showed that liver adiposity is independently associated with Insulin Resistance and can substantially increase the risk of various micro and macrovascular complications of diabetes mellitus.

Aims: Identifying various micro and macrovascular complications and finding their association with fatty liver disease in type 2 diabetes patients.

Material and methods: 141 diabetic patients admitted in a tertiary care center over a two year period were screened for fatty liver by ultrasonography of the abdomen and were classified into FL (fatty Liver) group and NFL (non fatty liver) group. All patients were investigated for complications like nephropathy, neuropathy, retinopathy, cardiac and peripheral vascular disease. Statistical analysis was done to find the association of complications with fatty liver.

Results: out of 141 patients, 49 (35%) had fatty liver. Leading complication was neuropathy (31.2%), followed by nephropathy (11.3%), retinopathy (10.6%), cardiac disease (9.2%) and peripheral vascular disease (3.55). Between FL and NFL groups, Diabetic neuropathy (40.8% vs 23.9%) and cardiac disease (16.3% vs 5.4%) showed statical significance (p<0.05), while other complications were more or less equally prevalent in the two groups.

Conclusions: Fatty liver is seen in one third of diabetic patients. vascular complications like neuropathy and cardiac disease are more commonly seen in diabetic patients with fatty liver than those without fatty liver.


Keywords


Fatty Liver, Diabetes, Vascular Complications.

References





DOI: https://doi.org/10.18311/ijmds%2F2014%2F80652